Exhaled nitric oxide in human lung ischemia-reperfusion

Disease Markers in Exhaled Breath

Volumn , Issue , 2002, Pages 259-279

  Kövesi, Tamás ^a   Royston, David ^a   Yacoub, Magdi H ^a,b   Marczin, Nándor ^a,b  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27844453487     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (68)

1. Schlensak C, Doenst T, Preusser S, Wunderlich M, Kleinschmidt M, Beyersdorf F. Bronchial artery perfusion during cardiopulmonary bypass does not prevent ischemia of the lung in piglets: Assessment of bronchial artery blood flow with fluorescent microspheres. Eur J Cardiothorac Surg 2001; 19(3):326-331.
2. Marczin N, Royston D, Yacoub M. Pro: lung transplantation should be routinely performed with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2000; 14:739-745.
3. Macnaughton PD, Braude S, Hunter DN, Denison DM, Evans TW. Changes in lung function and pulmonary capillary permeability after cardiopulmonary bypass. Crit Care Med 1992; 20(9):1289-1294.
4. Asimakopoulos G, Smith PL, Ratnatunga CP, Taylor KM. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg 1999; 68:1107-1115.
5. Asimakopoulos G, Taylor KM, Smith PL, Ratnatunga CP. Prevalence of acute respiratory distress syndrome after cardiac surgery. J Thorac Cardiovasc Surg 1999; 117: 620-621.
6. Messent M, Sullivan K, Keogh BF, Morgan CJ, Evans TW. Adult respiratory distress syndrome following cardiopulmonary bypass: incidence and prediction. Anaesthesia1992; 47:267-268.
7. Gammie JS, Cheul LJ, Pham SM, Keenan RJ, Weyant RJ, Hattler BG, et al. Cardiopulmonary bypass is associated with early allograft dysfunction but not death after double-lung transplantation. J Thorac Cardiovasc Surg 1998; 115:990-997.
8. Novick RJ, Gehman KE, Ali IS, Lee J. Lung preservation: the importance of endothelial and alveolar type II cell integrity. Ann Thorac Surg 1996; 62:302-314.
9. Khan SU, Salloum J, O’Donovan PB, Mascha EJ, Mehta AC, Matthay MA, et al.Acute pulmonary edema after lung transplantation: the pulmonary reimplantation response. Chest 1999; 116:187-194.
10. Kundu S, Herman SJ, Winton TL. Reperfusion edema after lung transplantation: radiographic manifestations. Radiology 1998; 206:75-80.
11. Christie JD, Bavaria JE, Palevsky HI, Litzky L, Blumenthal NP, Kaiser LR, et al.Primary graft failure following lung transplantation. Chest 1998; 114(1):51-60.
12. Serrick C, Giaid A, Reis A, Shennib H. Prolonged ischemia is associated with more pronounced rejection in the lung allograft. Ann Thorac Surg 1997; 63:202-208.
13. Qayumi AK, Nikbakht-Sangari MN, Godin DV, English JC, Horley KJ, Keown PA et al. The relationship of ischemia-reperfusion injury of transplanted lung and the up-regulation of major histocompatibility complex II on host peripheral lymphocytes. J Thorac Cardiovasc Surg 1998; 115:978-989.
14. Mal H, Dehoux M, Sleiman C, Boczkowski J, Leseche G, Pariente R, et al. Early release of proinflammatory cytokines after lung transplantation. Chest 1998; 113: 645-651.
15. Granger DN. Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation 1999; 6: 167-178.
16. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol2000; 190(3):255-266.
17. Freeman BA, Panus PC, Matalon S, Buckley BJ, Baker RR. Oxidant injury to the alveolar epithelium: biochemical and pharmacologic studies. Res Rep Health Eff Inst 1993; 1-30.
18. Verrier ED, Morgan EN. Endothelial response to cardiopulmonary bypass surgery. Ann Thorac Surg 1998; 66:S17-S19.
19. Boyle EM Jr, Pohlman TH, Cornejo CJ, Verrier ED. Endothelial cell injury in cardiovascular surgery: ischemia-reperfusion. Ann Thorac Surg 1996; 62(6):1868-1875.
20. Boyle EM Jr, Canty TG Jr, Morgan EN, Yun W, Pohlman TH, Verrier ED. Treating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription. Ann Thorac Surg 1999; 68(5):1949-1953.
21. Pillai R, Bando K, Schueler S, Zebly M, Reitz BA, Baumgartner WA. Leukocyte depletion results in excellent heart-lung function after 12 hours of storage. Ann Thorac Surg 1990; 50(2):211-214.
22. Bando K, Pillai R, Cameron DE, Brawn JD, Winkelstein JA, Hutchins GM, et al.Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990; 99(5):873-877.
23. Eppinger MJ, Deeb GM, Bolling SF, Ward PA. Mediators of ischemia-reperfusion injury of rat lung. Am J Pathol 1997; 150:1773-1784.
24. Eppinger MJ, Jones ML, Deeb GM, Bolling SF, Ward PA. Pattern of injury and the role of neutrophils in reperfusion injury of rat lung. J Surg Res 1995; 58:713-718.
25. Xing Z, Jordana M, Kirpalani H, Driscoll KE, Schall TJ, Gauldie J. Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation. Am J Respir Cell Molec Biol 1994; 10(2):148-153.
26. Kunkel SL, Lukacs N, Strieter RM. Expression and biology of neutrophil and endothelial cell-derived chemokines. Semin Cell Biol 1995; 6(6):327-336.
27. Binns OA, DeLima NF, Buchanan SA, Mauney MC, Cope JT, Thies SD, et al.Neutrophil endopeptidase inhibitor improves pulmonary function during reperfusion after eighteen-hour preservation. J Thorac Cardiovasc Surg 1996; 112(3):607-613.
28. 2 metabolites and neutrophil elastase synergistically cause edematous injury in isolated rat lungs. J Appl Physiol 1986; 61(6):2224-2229.
29. Steimle CN, Guynn TP, Morganroth ML, Bolling SF, Carr K, Deeb GM. Neutrophils are not necessary for ischemia-reperfusion lung injury. Ann Thorac Surg 1992; 53: 64-72.
30. Barnes PJ. Nitric oxide and airway disease. Ann Med 1995; 27(3):389-393.
31. Pinsky DJ. The vascular biology of heart and lung preservation for transplantation. Thromb Haemost 1995; 74(1):58-65.
32. Pinsky DJ, Naka Y, Chowdhury NC, Liao H, Oz MC, Michler RE, et al. The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. Proc Natl Acad Sci USA 1994; 91(25):12086-12090.
33. Barnes PJ. Nitric oxide and airway disease. Ann Med 1995; 27(3):389-393.
34. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-142.
35. Guo FH, De Raeve HR, Rice TW, Stuehr DJ, Thunnissen FB, Erzurum SC. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci USA 1995; 92:7809-7813.
36. Asano K, Chee CB, Gaston B, Lilly CM, Gerard C, Drazen JM, et al. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci USA 1994; 91:10089-10093.
37. Dweik RA, Laskowski D, Abu-Soud HM, Kaneko F, Hutte R, Stuehr DJ, et al. Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J Clin Invest 1998; 101(3):660-666.
38. Phelan MW, Faller DV. Hypoxia decreases constitutive nitric oxide synthase transcript and protein in cultured endothelial cells. J Cell Physiol 1996; 167(3):469-476.
39. Nelin LD, Thomas CJ, Dawson CA. Effect of hypoxia on nitric oxide production in neonatal pig lung. Am J Physiol 1996; 271(1 Pt 2):H8-H14.
40. Ziesche R, Petkov V, Mosgoller W, Block LH. Regulation of human endothelial nitric oxide synthase by hypoxia and inflammation in human pulmonary arteries— implications for the therapy of pulmonary hypertension in COPD patients. Acta An-aesthesiol Scand Suppl 1996; 109:97-98.
41. Zweier JL, Samouilov A, Kuppusamy P. Non-enzymatic nitric oxide synthesis in biological systems. Biochim Biophys Acta 1999; 1411(2-3):250-262.
42. Modin A, Bjorne H, Herulf M, Alving K, Weitzberg E, Lundberg JO. Nitrite-derived nitric oxide: A possible mediator of ‘acidic-metabolic’ vasodilation. Acta Physiol Scand 2001; 171(1):9-16.
43. Hunt JF, Fang K, Malik R, Snyder A, Malhotra N, Platts-Mills TA, et al. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 2000; 161(3 Pt 1):694-699.
44. Royall JA, Kooy NW, Beckman JS. Nitric oxide-related oxidants in acute lung injury. New Horiz 1995; 3(1):113-122.
45. Freeman BA, White CR, Gutierrez H, Paler-Martinez A, Tarpey MM, Rubbo H, et al. Oxygen radical-nitric oxide reactions in vascular diseases. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Adv Pharmacol 1995; 34:45-69.
46. Freeman BA, Gutierrez H, Rubbo H. Nitric oxide: A central regulatory species in pulmonary oxidant reactions [editorial; comment]. Am J Physiol 1995; 268:L697-L698.
47. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87:1620-1624.
48. O’Donnell VB, Freeman BA. Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease. Circ Res 2001; 88:12-21.
49. Marczin N, Chen X, Catravas JD. Basal release of EDRF under conditions of oxidant stress. In: Catravas JD, Callow AD, Ryan US, eds. Vascular Endothelium: Physiological Basis of Clinical Problems II. New York: Plenum, 1993:3-16.
50. Liu M, Tremblay L, Cassivi SD, Bai XH, Mourgeon E, Pierre AF, et al. Alterations of nitric oxide synthase expression and activity during rat lung transplantation. Am J Physiol Lung Cell Mol Physiol 2000; 278(5):L1071-L1081.
51. Itano H, Zhang W, Ritter JH, McCarthy TJ, Mohanakumar T, Patterson GA. Adenovirus-mediated gene transfer of human interleukin 10 ameliorates reperfusion injury of rat lung isografts. J Thorac Cardiovasc Surg 2000; 120(5):947-956.
52. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991; 181(2):852-857.
53. Pietropaoli AP, Perkins PT, Perillo IB, Hyde RW. Exhaled nitric oxide does not provide a marker of vascular endothelial function in healthy humans [letter; comment]. Am J Respir Crit Care Med 2000; 161:2113-2114.
54. Cremona G, Higenbottam T, Takao M, Hall L, Bower EA. Exhaled nitric oxide in isolated pig lungs. J Appl Physiol 1995; 78(1):59-63.
55. Sartori C, Lepori M, Busch T, Duplain H, Hildebrandt W, Bartsch P, et al. Exhaled nitric oxide does not provide a marker of vascular endothelial function in healthy humans [see comments]. Am J Respir Crit Care Med 1999; 160:879-882.
56. Kharitonov SA, Barnes PJ. Nitric oxide in exhaled air is a new marker of airway inflammation. Monaldi Arch Chest Dis 1996; 51(6):533-537.
57. Persson MG, Agvald P, Gustafsson LE. Detection of nitric oxide in exhaled air during administration of nitroglycerin in vivo. Br J Pharmacol 1994; 111:825-828.
58. Cederqvist B, Persson MG, Gustafsson LE. Direct demonstration of no formation in vivo from organic nitrites and nitrates, and correlation to effects on blood pressure and to in vitro effects. Biochem Pharmacol 1994; 47:1047-1053.
59. Marczin N, Riedel B, Royston D, Yacoub M. Intravenous nitrate vasodilators and exhaled nitric oxide. Lancet 1997; 349:1742-1742.
60. Marczin N, Riedel B, Royston D, Yacoub M. Exhaled nitric oxide and pulmonary response to iloprostin systemic sclerosis [letter; comment]. Lancet 1998; 352(9125): 405-406.
61. Marczin N, Riedel B, Gal J, Polak J, Yacoub M. Exhaled nitric oxide during lung transplantation [letter]. Lancet 1997; 350(9092):1681-1682.
62. Marczin N, Ryan US, Catravas JD. Effects of oxidant stress on endothelium-derived relaxing factor-induced and nitrovasodilator-induced cGMP accumulation in vascular cells in culture. Circ Res 1992; 70(2):326-340.
63. Beghetti M, Silkoff PE, Caramori M, Holtby HM, Slutsky AS, Adatia I. Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass-induced injury. Ann Thorac Surg 1998; 66:532-534.
64. Hill GE, Snider S, Galbraith TA, Forst S, Robbins RA. Glucocorticoid reduction of bronchial epithelial inflammation during cardiopulmonary bypass. Am J Respir Crit Care Med 1995; 152:1791-1795.
65. Brett SJ, Quinlan GJ, Mitchell J, Pepper JR, Evans TW. Production of nitric oxide during surgery involving cardiopulmonary bypass [see comments]. Crit Care Med1998; 26(2):272-278.
66. Ishibe Y, Liu R, Hirosawa J, Kawamura K, Yamasaki K, Saito N. Exhaled nitric oxide level decreases after cardiopulmonary bypass in adult patients. Crit Care Med2000; 28:3823-3827.
67. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med2000; 342:1334-1349.
68. Ware LB, Golden JA, Finkbeiner WE, Matthay MA. Alveolar epithelial fluid transport capacity in reperfusion lung injury after lung transplantation. Am J Respir Crit Care Med 1999; 159(3):980-988.